IMO, BAL I think will max out on the SP front once FY16 is over, with the greatest potential for a significant rise in SP being February after half year announcement which I think at a conservative estimate be somewhere around the $35 mil forecast mark. Unless of course they can increase productivity and source extra ingredients form somewhere. A2M on the other hand have a few different fraction and I believe more potential in the long run. IMO quick buck on BAL soon, A2M at some stage in the future once US and UK operations are sorted. BFC is working a look into too IMO, still in the early stages of setting up a formula supply but when they do it could have some interesting outcomes. BKL can set up formula production quickly but I'm thinking thats already been factored into the SP so any ST gains won't be for a while yet. Let's just hope there's no formula poisoning scandals coming from Australia, happened to karicare. As always all IMO and DYOR is always very advisable.
BAL Price at posting:
$13.02 Sentiment: Buy Disclosure: Held
